Bond And Money Market

We present a matrix detailing some movement in some key market rates (domestic and global) and key events:

Parameters 31-Mar-21 26-Feb-21 31-Mar-20
RBI Repo Rate % 4.00 4.00 4.40
5Y AAA PSU % 6.14 6.01 6.53
1 year CD % 4.38 4.25 5.12
10Y Gsec % 6.17 6.23 6.14
CPI (%) 5.03 4.06 6.58
IIP (YoY) % -1.6 1.56 2.23
US 10Y % 1.74 1.40 0.67
Dollar Rupee 73.11 73.46 75.54
EUR 10Y % -0.53 -0.39 -0.57

Source: Bloomberg; Data as on March 31st 2021

It was steady month for the domestic debt markets. After a sharp rise in yield in February, the markets witnessed an element of consolidation. The benchmark 10 year Gsec eased marginally by around 6 basis points (bps) to close at 6.17 %. The money market rates inched up marginally as the mutual funds witnessed some customary outflows in their schemes during the Financial year end. The US sovereign 10 year continued to inch up through the month and It closed at close to 1.74 percent, moving up by around 35 bps through the month. With the Biden administration announcing large stimulus and infrastructure spending plans, the possibility of a reflation trade and a rising US bond yields remain a distinct possibility.

The Government of India announced its borrowing calendar for the first half of 2021-2022. The Government proposes to borrow close to 60 % of its budgeted borrowing in the first half, which was broadly in line with the street estimates. The borrowing looks fairly evenly distributed with close to 50 percent of the borrowing in the 10 year and below segment. Inflation measured by CPI inched up to 5.03% and core inflation continue to remain at an elevated level.

Looking Ahead
  • The MPC met for its bi-monthly monetary policy. This meeting comes after the Government had maintained a status quo on the inflation targeting at 4 % with a margin of 2 percent for the MPC for the next five years.
    While the consensus of a no change in policy rates and a continued accommodative policy stance remained unaltered, there were certain key elements in the policy statements.
    • The accommodative policy was not time dependent (like the previous policies which had talked about being accommodative through FY 22) but was dependent on pursuing accommodative policy till durable growth was observed
    • The inflation forecast for 1HFY22 has been raised very mildly, at 5.2% per cent in Q1-Q2 of FY22, 4.4% Q3 and 5.1% in Q4, with risks broadly balanced -- strong food production output and to be countered by possible cost push pressures. The FY22 real GDP growth projection stays unchanged at 10.5%
    • Launch of a secondary market buying of GSec of INR 1 trillion for the quarter It was a dovish policy with possible hints of a gradual flattening of the yield curve
  • However, we remain apprehensive of a gradual rate rise as we move through the year. We believe that the markets may stop coat tailing the RBI, and are not ignoring a commodity prices rise induced inflation and a larger borrowing program
  • The possibility of a bear flattening of the yield curve exists with long term rates rising lesser than short term rates
  • Liquidity being in sustained surplus mode, the extreme short end of the yield curve may remain stable.
Scheme Specific Strategies for Debt schemes
  • Mahindra Manulife Low Duration Fund
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 133 days
    • We would maintain a similar maturity as we move ahead
    • The YTM of the portfolio is around 3.84%
    • With surplus liquidity conditions, we expect the extreme short end money market rates to remain benign
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
  • Mahindra Manulife Credit Risk Fund
    • We intend to hold the cash in the portfolio for some time in the future and re-deploy the same as uncertainties recedes and investor confidence returns in debt markets
    • The YTM of the portfolio has decreased to around 4.96%.
    • The Modified Duration of the portfolio is around 1.34 years
  • Mahindra Manulife Short Term Fund
    • We are in the process of the portfolio construction as per the mandate of the scheme
    • We intend to be at the lower end of the permissible Macaulay Duration range as we create the portfolio
Equity Market outlook and overview

We present a summary of changes in key Indian& Global equity indices

NAME S&P BSE Sensex Nifty 50 BSE Midcap BSE Small Cap Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance 0.8% 1.1% 1.0% 2.5% 1.8% 0.8% 6.6% 4.2% 0.4%
1 Yr Performance 68.0% 70.9% 90.9% 114.9% 102.4% 125.7% 50.5% 53.7% 72.0%

Source: Bloomberg Performance - Absolute returns | Data as on Mar 31, 2021

Equity Market Update

Indian markets had a volatile month with reasonable swings on both side and ended with marginal gains. During the month, India started experiencing second phase of Covid cases in few states. Rapid rise in the financial capital -- Mumbai -- as well as in many parts of Maharashtra, led to fears lockdown. Due to these fears, stock markets actually gave up much of the gains seen during last month post-Budget, but rallied towards month-end to post marginal net gains. Mid- and Small-Cap indices fared slightly better than Nifty as focus has shifted on broader markets with economy traction visible. This is again quite similar to broader trends across the global markets where recovery is broad-based. Among large sectors in market; FMCG, IT, Metals and Pharma outperformed Nifty while Financials, Auto, Energy underperformed Nifty. The broad trend of rotation amongst sectoral indices continues in Indian markets as leaders change almost every month. We present below the monthly sectoral as well as market-cap based leadership details for FY21 9 (Index Performance - Month on Month) that can best be rationalised as a relay race where every participant (sector) does their bit before passing the baton to next participant. From FII flow perspective, India’s stock markets continue to attract flows though it has moderated vis-a-vis last 4-5 months.

Indices Apr-20 May-20 Jun-20 Jul-20 Aug-20 Sep-20 Oct-20 Nov-20 Dec-20 Jan-21 Feb-21 Mar-21 FY21
NIFTY 50 14.7 -2.8 7.5 7.5 2.8 -1.2 3.5 11.4 7.8 -2.5 6.6 1.1 70.9 Top
NIFTY Midcap 100 15.4 -1.7 10.8 5.2 7.8 1.8 0.5 15.5 5.7 0.3 11.3 1.8 102.4 Bottom
NIFTY Small Cap 100 13.4 -1.8 15.3 8.6 11.5 4.2 -0.1 13.0 7.8 1.3 12.2 0.8 125.7
NIFTY Auto 24.7 5.4 8.0 8.3 7.7 0.9 -1.9 14.6 3.4 6.7 3.6 -3.0 108.5 Top 2
NIFTY Bank 12.5 -10.4 10.7 1.3 9.8 -9.7 11.4 23.9 5.6 -2.2 13.9 -4.3 74.0 Bottom 2
NIFTY Financial Services 13.5 -9.9 10.9 1.6 6.2 -6.7 9.5 22.8 6.4 -4.0 10.2 -2.3 68.7
NIFTY FMCG 4.9 2.2 2.6 2.7 -0.9 -2.5 -1.4 7.8 7.8 -3.1 -2.0 7.7 27.9
NIFTY IT 10.5 -0.7 5.3 22.5 -0.8 11.3 4.8 4.1 11.4 1.6 -1.4 6.4 102.6
NIFTY Media 11.5 1.6 14.1 -4.3 22.4 -1.6 -8.3 5.9 9.7 0.1 -1.5 -4.9 48.6
NIFTY METAL 17.3 1.1 5.9 7.8 12.7 -7.4 4.5/td> 24.8 11.2 -5.4 24.2 4.0 150.8
NIFTY Media 11.5 1.6 14.1 -4.3 22.4 -1.6 -8.3 5.9 9.7 0.1 -1.5 -4.9 48.6
NIFTY Realty 6.7 -3.8 12.5 -0.8 10.8 -4.9 7.7 14.5 20.2 -2.6 14.4 -4.5 90.4
NIFTY Pharma 30.0 4.7 2.2 11.7 -0.6 6.3 -4.5 5.3 9.1 -5.8 -2.0 2.9 71.0
NIFTY ENERGY 18.3 -0.7 10.2 6.3 1.9 -3.7 -0.3 8.5 4.1 -4.5 16.3 -3.2 63.5
DOW JONES INDUS. AVG 11.1 4.3 1.7 2.4 7.6 -2.3 -4.6 11.8 3.3 -2.0 3.2 6.6 50.5 Top 2
S&P 500 INDEX 12.7 4.5 1.8 5.5 7.0 -3.9 -2.8 10.8 3.7 -1.1 2.6 4.2 53.7 Bottom 2
NASDAQ 15.4 6.8 6.0 6.8 9.6 -5.2 -2.3 11.8 5.7 1.4 0.9 0.4 72.0
FTSE 100 INDEX 4.0 3.0 1.5 -4.4 1.1 -1.6 -4.9 12.4 3.1 -0.8 1.2 3.6 18.4
CAC 40 INDEX 4.0 2.7 5.1 -3.1 3.4 -2.9 -4.4 20.1 0.6 -2.7 5.6 6.4 38.0
DAX INDEX 9.3 6.7 6.2 0.0 5.1 -1.4 -9.4 15.0 3.2 -2.1 2.6 8.9 51.1
NIKKEI 225 6.7 8.3 1.9 -2.6 6.6 0.2 -0.9 15.0 3.8 0.8 4.7 0.7 54.2
HANG SENG INDEX 4.4 -6.8 6.4 0.7 2.4 -6.8 2.8 9.3 3.4 3.9 2.5 -2.1 20.2
NIFTY 50 14.7 -2.8 7.5 7.5 2.8 -1.2 3.5 11.4 7.8 -2.5 6.6 1.1 70.9

Source: Bloomberg | Absolute returns

Globally, equity as an asset class continues to remain in bullish mode as the expectations of economic recovery gets stronger along with the rising pace of vaccination. The economic data flow too has entered an extremely favourable phase as disruption during lockdown has now set into the base year. The commentary by US Federal Reserve clearly suggests that the monetary policies are likely to remain benign despite inflationary expectations. As usual with all economic data, there are two camps on expectations on inflation. The dovish camp has a view that inflation is caused more due to supply constraints and logistics issue. As these gets normalised the demand supply equilibrium would be met and inflation would moderate. The hawkish view on inflation is emanating from the higher fiscal deficit that many countries (especially US with US FED focusing more inflation) are likely to resort to tide over the growth concerns caused by Covid-19. Another reason for inflationary expectations is due to the rising commodity prices as fiscal deficit is expected to be driven by capex cycle and infra spend in quite a few countries. The inflation debate is quite relevant for financial markets as low interest rates (due to low inflation) has been a primary driver of valuations that has led to higher asset valuations. From pure equity market perspective, the interest rates direction is also critical as that can set the market preference for growth v/s value stocks. Lower interest rates favour growth stocks as investors are willing to look more long-term to justify valuations while higher rates favour value stocks as immediate earnings get more attention.

Indian economy continues to see strong normalisation with improving data across parameters. As mentioned earlier, we have entered a favourable base period so we can continue to expect a series of good growth data across sectors for next 4-5 months. The consensus has now shifted towards a strong growth in FY22 with estimates ranging from 8% to 13%. These estimates put India as amongst the fastest growing economies in FY22.

Government continues to focus on key initiatives on creating infrastructure as well as conducive policy framework to attract private sector participation in capex cycle by offering growth opportunities under “PLI schemes”. While the real benefits are more likely over next 2-3-5 years the sentiments are far more positive for now.

The corporate results for Q4FY21 would commence now and key area to watch would be the results declared by Banks and NBFCs. They would be required to disclose true picture on NPAs, as per the asset quality norms post Supreme Court’s verdict in March. The impact of a bad FY21 (de-growth of around 8% expected in GDP) on asset quality is worth monitoring as it would set base for lender’s ability to participate in credit growth going ahead. In terms of other sectors, key trends to be monitored would be impact of rising commodity prices. The corporate profits have been quite strong in 9M FY21 where a significant contribution has been from cost savings. Key challenge for corporate profitability for FY22 would arise from the impact of commodity costs as well as normalisation of operating costs (in line with normalisation of economic activities). The commentary from corporates would provide some indications on this front.

Looking Ahead

While the benign phase has begun on the economic front, the resurgence of Covid-19 cases in many countries has created some clouds of worry. Clearly, the markets are not prepared for any fresh clampdowns on economic activities. We hope that virus spread is contained quickly and there is no damage to the fundamental recovery in economic activity.

From valuations perspective, inflation scare in US and its impact on interest rates remain a key monitorable as it can impact asset prices.

The market behaviour in last 12-months has been quite stark and interesting. A closer look at top 10 outperformers and underperformers among NIFTY companies in two years, FY20 and in FY21 as shown in the charts below (Leaders and Laggards of Nifty Index in FY 2019-20 ), throws some interesting data points. Six of the top 10 outperformers of FY21 were among the top 10 underperformers in FY20! Equally interesting is that four of the top 10 underperformers of FY21 were among the top 10 outperformers in FY20. The data again re-iterates that markets undergo phases of greed and fear, where preferences and likings go through volatile phases.

Risk (Uncertainty in Markets) has its own relationship with Returns and there are perhaps two ways to manage such greed and fear phase. Investors with lumpsum investments could have an asset allocation strategy (equity as a % of portfolio) to try and benefit from greed and fear phases. Alternately, the strategy is to really stick to longer term outlook rather than focussing on 1-2 years volatility. For investors with SIP investments however such phases are not so relevant as investor is still in accumulation phase for potential wealth creation over the 5-7 years. SIP may be a good alternate to avoid the behavioural traps during the extreme phases of markets. We maintain that Investors may use SIP as part of core investment philosophy and use the lumpsum route during the extreme phases to top-up on their SIPs during the fearful times amidst the volatility.

Scheme Specific Strategies for Equity schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
  • Mahindra Manulife ELSS Kar Bachat Yojana
  • Mahindra Manulife Rural Bharat and Consumption Yojana
  • Mahindra Manulife Large Cap Pragati Yojana
  • Mahindra Manulife Top 250 Nivesh Yojana
  • Mahindra Manulife Focused Equity Yojana
Scheme Specific Strategies For Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.

    Debt:

    • The Modified duration of the portfolio is around 3.77 years of the debt portion
    • The current asset allocation has an equal allocation to AAA credits and GoI securities
What should an investor do?

For investments in debt oriented products:

  • We believe that the investors with a shorter investment horizon may continue investments in ultra-short term and low duration funds
  • For a medium to long term investment horizon and with a suitable risk appetite, an allocation to short term fund merits attention

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • We believe investors with shorter investment horizon and lower risk appetite, may invest in arbitrage fund to hedge against volatility
  • Investors looking to invest for a longer period, can consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in the mid cap scheme as well.

Select Mutual Fund Regulatory Updates from April 2021

New Nomenclature for Dividend as Income Distribution Cum Capital Withdrawal (IDCW)

As per SEBI Circular dated October 5, 2020, Dividend option will be now known as Income Distribution cum Capital Withdrawal option, to add clarity that certain portion of the capital (Equalization Reserve) can be distributed as dividend. Accordingly, investments in dividend plans, will appear in new nomenclature:

  • In account statements and capital gains statements
  • Across all AMC investment platforms – AMC website & mobile application
  • Across all CAMS, MFU, BSE, NSE and other investment platforms

HUFs and Sole Proprietors Have to Provide Non-Individual CKYC Details

For the purpose of completion of new KYC or modification to the existing details in KYC records as per new regulations, HUF and sole proprietors shall be required to submit new non-individual CKYC form at any of the cams service centres. However, existing folio(s) can be operated without any hassle.

Fund’s Legal Entity Identifier (LEI) Is Mandatory for All Non Individual Investors for transactions of Rs 50 crores and above

Investors can contact our service team to get the LEI of Mahindra Manulife Mutual Fund’s (Fund) for payment transactions of value of Rs 50 crores and above, initiated through RTGS or NEFT systems and also provide their LEI to the Fund for redemptions of value of Rs 50 crores and above.

Scheme Name Product Suitability Riskometer
Mahindra Manulife Overnight Fund
An open ended debt scheme investing in overnight securities
This Product is suitable for investors who are seeking*:
  • To generate reasonable returns with high levels of safety and convenience of liquidity over short term
  • To invest in debt and money market instruments having maturity of upto 1 business day
Mahindra Manulife Arbitrage Yojana
An open ended scheme investing in arbitrage opportunities
This Product is suitable for investors who are seeking*:
  • Income over short term
  • Income through arbitrage opportunities between cash and derivative market and arbitrage opportunities within the derivative segment.
Mahindra Manulife Liquid Fund
An Open Ended Liquid scheme
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
Mahindra Manulife Short Term Fund
An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years (please refer to page no. 35 of SID)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
Mahindra Manulife Low Duration Fund
An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months (Please refer page 31 of SID)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in debt and money market instruments
Mahindra Manulife Ultra Short Term Fund
An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months (please refer to page no. 31 of SID)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
Mahindra Manulife Credit Risk Fund
An open ended debt scheme predominantly investing in AA and below rated corporate bonds (excluding AA+ rated corporate bonds)
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation over medium term.
  • Investment predominantly in AA and below rated corporate bonds, debt, government securities and money market instruments while maintaining the optimum balance of yield, safety and liquidity.
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
An open ended scheme investing in equity, arbitrage and debt
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments
Mahindra Manulife ELSS Kar Bachat Yojana
An open ended equity linked saving scheme with a statutory lock in of 3 years and tax benefit
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities
Mahindra Manulife Focused Equity Yojana
An open ended equity scheme investing in maximum 30 stocks across market caps (i.e Multi Cap)
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated profile of maxium 30 stocks across market capitalziation.
Mahindra Manulife Top 250 Nivesh Yojana
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and Mid cap companies.
Mahindra Manulife Multi Cap Badhat Yojana
Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives.
Mahindra Manulife Mid Cap Unnati Yojana
Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies
Mahindra Manulife Large Cap Pragati Yojana
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Mahindra Manulife Hybrid Equity Nivesh Yojana
An open ended hybrid scheme investing predominantly in equity and equity related instruments
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income;
  • Investment in equity and equity related instruments and debt and money market instruments
Mahindra Manulife Rural Bharat and Consumption Yojana
An open ended scheme following Rural India theme
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/ or expected to benefit from the growth in rural India.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno. 00933

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.